✦ LIBER ✦

Weekly carboplatin (CARBO) plus chronic oral etoposide (VP-16) as first line therapy in small cell lung cancer (SCLC). A phase II trial

✍ Scribed by Palombo, H; Estapé, J; Grau, JJ; Agustí, C; Sanchez-Lloret, J; Mellado, B; Mañé, JM

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Etoposide (VP-16) and carboplatin as a f

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Oral etoposide (VP-16) and IV carboplati

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 135 KB

A phase II trial with oral etoposide (VP

✍ Gracia, J.M.; Fernández, R.; Cueva, J.; Virizuela, J.A.; García, E.; Sanz, A.; L 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Phase II trial with weekly cisplatin (CD

✍ Lopez, R.; Fernandez, R.; Virizuela, J.A.; Cueva, J.; Garcia, E.; Sanz, A.; Vale 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I–II study of carboplatin, epirubi

✍ Gridelli, C.; D'Aprile, M.; Palmeri, S.; Curcio, C.; Gebbia, V.; Veltri, E.; Ian 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Ifosfamide, epirubicin and vincristine a

✍ Rodrígeuz, CA; Martín, G; López, Y; Cruz, JJ 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 117 KB